Radioiodine therapy for papillary and follicular thyroid carcinoma

Michele Klain; Marcel Ricard; Sophie Leboulleux; Eric Baudin; Martin Schlumberger

doi:10.1007/s00259-002-0810-9

Radioiodine therapy for papillary and follicular thyroid carcinoma

Michele Klain, Marcel Ricard, Sophie Leboulleux, Eric Baudin, Martin Schlumberger

Research output: Contribution to journal › Review article › peer-review

51 Citations (Scopus)

Abstract

Radioiodine (¹³¹I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.

Original language	English
Pages (from-to)	S479-S485
Journal	European Journal of Nuclear Medicine
Volume	29
DOIs	https://doi.org/10.1007/s00259-002-0810-9
Publication status	Published - 1 Jan 2002

Keywords

Ablation
Metastases
Radioiodine
Thyroid carcinoma

Access to Document

10.1007/s00259-002-0810-9

Cite this

@article{0984dbe41c0a4127823cc907a0a76a65,

title = "Radioiodine therapy for papillary and follicular thyroid carcinoma",

abstract = "Radioiodine (131I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.",

keywords = "Ablation, Metastases, Radioiodine, Thyroid carcinoma",

author = "Michele Klain and Marcel Ricard and Sophie Leboulleux and Eric Baudin and Martin Schlumberger",

year = "2002",

month = jan,

day = "1",

doi = "10.1007/s00259-002-0810-9",

language = "English",

volume = "29",

pages = "S479--S485",

journal = "European Journal of Nuclear Medicine",

issn = "0340-6997",

}

TY - JOUR

T1 - Radioiodine therapy for papillary and follicular thyroid carcinoma

AU - Klain, Michele

AU - Ricard, Marcel

AU - Leboulleux, Sophie

AU - Baudin, Eric

AU - Schlumberger, Martin

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Radioiodine (131I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.

AB - Radioiodine (131I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.

KW - Ablation

KW - Metastases

KW - Radioiodine

KW - Thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0036373149&partnerID=8YFLogxK

U2 - 10.1007/s00259-002-0810-9

DO - 10.1007/s00259-002-0810-9

M3 - Review article

C2 - 12192549

AN - SCOPUS:0036373149

SN - 0340-6997

VL - 29

SP - S479-S485

JO - European Journal of Nuclear Medicine

JF - European Journal of Nuclear Medicine

ER -

Radioiodine therapy for papillary and follicular thyroid carcinoma

Abstract

Keywords

Access to Document

Other files and links

Cite this